Detected on Tuesday 27 October, 15h27
Xolair becomes substitutable in pharmacies by its biosimilar Omlyclo
Omalizumab (Xolair) becomes substitutable in pharmacies by its biosimilar Omlyclo, a change in how this treatment is dispensed.
In brief
Health event (severity: info) nationwide, first detected on 27 October 2026 at 15:27. Reported by 1 source (1 article), last updated on 27 October 2026 at 15:27.
- Category
- Health
- Severity
- Info
- Place
National
- Detected
- 27 Oct, 15h27
- Updated
- 27 Oct, 15h27
- Reference
- no.3393
1 article · 1 source · no rated outlet covers this topic yet (public service, agencies, official accounts…)
Angle comparison
A comparison is written as soon as the event is covered by at least two sides (left, centre, right).
Lire les sources · 1 article, 1 source
- 15h27Le Moniteur des pharmaciesWirevia Google Actualités France27 OctOmalizumab : Xolair devient substituable en officine par son biosimilaire Omlyclo - Le Moniteur des pharmacies
Omalizumab : Xolair devient substituable en officine par son biosimilaire Omlyclo Le Moniteur des pharmacies
Further reading
Organisations cited
Keywords
#médicament · #biosimilaire · #Xolair · #pharmacie
Go up the thread
People and organisations cited